CA Stock MarketDetailed Quotes
MDMA Pharmala Biotech Holdings Inc
- 0.295
- +0.015+5.36%
15min DelayMarket Closed Nov 22 15:59 ET
28.44MMarket Cap-36875P/E (TTM)
0.295High0.230Low822.44KVolume0.270Open0.280Pre Close221.92KTurnover0.35052wk High0.85%Turnover Ratio96.40MShares0.06552wk Low-0.008EPS TTM28.44MFloat Cap0.540Historical HighLossP/E (Static)96.40MShs Float0.005Historical Low-0.01EPS LYR23.21%Amplitude--Dividend TTM21.07P/B1Lot Size--Div YieldTTM
Pharmala Biotech Holdings Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | (Q3)May 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -94.49%40.35K | -69.49%222.85K | -77.11%195.04K | -77.11%195.04K | -58.70%495.99K | -60.42%731.72K | -65.98%730.47K | -65.53%852.14K | --852.14K | --1.2M |
| -Cash and cash equivalents | -94.49%40.35K | -69.49%222.85K | -77.11%195.04K | -77.11%195.04K | -58.70%495.99K | -60.42%731.72K | -65.98%730.47K | -65.53%852.14K | --852.14K | --1.2M |
| Receivables | 361.92%395.01K | 127.10%285.39K | 342.11%223.49K | 342.11%223.49K | -60.18%27.91K | -29.12%85.52K | 56.72%125.67K | -15.15%50.55K | --50.55K | --70.1K |
| -Accounts receivable | 85.68%112.95K | 68.45%123.68K | 739.76%194.96K | 739.76%194.96K | --0 | -35.97%60.83K | --73.43K | --23.22K | --23.22K | ---- |
| -Taxes receivable | 268.53%76.24K | -3.17%46.71K | 5.13%24.53K | 5.13%24.53K | -63.82%23.91K | -4.41%20.69K | -36.68%48.24K | -58.02%23.33K | --23.33K | --66.1K |
| -Other receivables | 5,467.33%222.69K | 3,196.38%131.86K | 0.00%4K | 0.00%4K | 0.00%4K | 0.00%4K | 0.00%4K | 0.00%4K | --4K | --4K |
| -Recievables adjustments allowances | ---16.86K | ---16.86K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Inventory | -91.27%10.16K | -91.27%10.16K | 5.03%122.19K | 5.03%122.19K | 92.16%218.13K | --116.34K | --116.34K | --116.34K | --116.34K | --113.52K |
| Prepaid assets | 195.98%236.04K | 365.83%129.07K | 160.72%173.23K | 160.72%173.23K | 47.91%86.46K | -6.47%79.75K | 261.02%27.71K | --66.44K | --66.44K | --58.46K |
| Total current assets | -32.74%681.56K | -35.27%647.47K | -34.23%713.95K | -34.23%713.95K | -42.58%828.5K | -50.68%1.01M | -55.25%1M | -57.13%1.09M | --1.09M | --1.44M |
| Non current assets | ||||||||||
| Net PPE | -57.30%1.26K | -50.41%1.67K | -44.67%2.1K | -44.67%2.1K | -39.90%2.53K | -36.56%2.95K | -33.80%3.38K | 60.70%3.8K | --3.8K | --4.21K |
| -Gross PPE | 0.00%5.66K | 0.00%5.66K | 0.00%5.66K | 0.00%5.66K | 0.00%5.66K | 0.00%5.66K | 0.00%5.66K | 112.07%5.66K | --5.66K | --5.66K |
| -Accumulated depreciation | -62.60%-4.4K | -74.65%-3.98K | -91.38%-3.55K | -91.38%-3.55K | -116.18%-3.13K | -170.03%-2.7K | -310.07%-2.28K | -512.87%-1.86K | ---1.86K | ---1.45K |
| Goodwill and other intangible assets | 30.28%1.8M | 28.88%1.74M | 36.72%1.7M | 36.72%1.7M | 74.69%1.44M | 135.37%1.38M | 334.98%1.35M | 378.12%1.24M | --1.24M | --824.26K |
| -Other intangible assets | 30.28%1.8M | 28.88%1.74M | ---- | ---- | --1.44M | --1.38M | --1.35M | ---- | ---- | ---- |
| Total non current assets | 30.09%1.8M | 28.68%1.74M | 36.47%1.7M | 36.47%1.7M | 74.10%1.44M | 134.02%1.38M | 329.01%1.35M | 375.26%1.24M | --1.24M | --828.47K |
| Total assets | 3.52%2.48M | 1.48%2.39M | 3.54%2.41M | 3.54%2.41M | -0.02%2.27M | -9.41%2.4M | -7.77%2.35M | -16.60%2.33M | --2.33M | --2.27M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current deferred liabilities | 18.56%399.07K | -12.24%283.19K | 750.55%443.32K | 750.55%443.32K | --387.58K | 7,827.23%336.59K | 7,501.32%322.68K | --52.12K | --52.12K | ---- |
| Current liabilities | 50.98%1.14M | 26.64%878K | 142.82%1.03M | 142.82%1.03M | 171.51%812.35K | 56.49%753.89K | 417.80%693.3K | 206.03%423.78K | --423.78K | --299.2K |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | 50.98%1.14M | 26.64%878K | 142.82%1.03M | 142.82%1.03M | 171.51%812.35K | 56.49%753.89K | 417.80%693.3K | 206.03%423.78K | --423.78K | --299.2K |
| Shareholders'equity | ||||||||||
| Share capital | 8.90%5.26M | 8.90%5.26M | 6.37%5.14M | 6.37%5.14M | 6.37%5.14M | 0.00%4.83M | 0.00%4.83M | 120.03%4.83M | --4.83M | --4.83M |
| -common stock | 8.90%5.26M | 8.90%5.26M | 6.37%5.14M | 6.37%5.14M | 6.37%5.14M | 0.00%4.83M | 0.00%4.83M | 120.03%4.83M | --4.83M | --4.83M |
| Additional paid-in capital | -8.56%399.73K | -18.28%343.14K | -0.74%376.36K | -0.74%376.36K | 46.32%371.09K | 82.80%437.15K | 103.73%419.9K | 165.85%379.15K | --379.15K | --253.61K |
| Retained earnings | -16.30%-4.32M | -8.27%-4.1M | -18.25%-4.13M | -18.25%-4.13M | -22.67%-4.05M | -19.90%-3.71M | -34.55%-3.78M | -39.28%-3.49M | ---3.49M | ---3.3M |
| Other equity interest | ---- | ---- | ---- | ---- | ---- | -54.14%87.26K | 0.00%190.27K | -93.27%190.27K | --190.27K | --190.27K |
| Total stockholders'equity | -18.25%1.34M | -9.03%1.51M | -27.42%1.38M | -27.42%1.38M | -26.05%1.46M | -24.09%1.64M | -31.35%1.66M | -28.21%1.91M | --1.91M | --1.97M |
| Total equity | -18.25%1.34M | -9.03%1.51M | -27.42%1.38M | -27.42%1.38M | -26.05%1.46M | -24.09%1.64M | -31.35%1.66M | -28.21%1.91M | --1.91M | --1.97M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data